Scientific Reports (Jan 2024)
Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice
- Tomoyuki Homma,
- Noriyo Nagata,
- Masayuki Hashimoto,
- Naoko Iwata-Yoshikawa,
- Naomi M. Seki,
- Nozomi Shiwa-Sudo,
- Akira Ainai,
- Keiji Dohi,
- Eiji Nikaido,
- Akiko Mukai,
- Yuuta Ukai,
- Takayuki Nakagawa,
- Yusuke Shimo,
- Hiroki Maeda,
- Seiki Shirai,
- Miwa Aoki,
- Takuhiro Sonoyama,
- Mamoru Sato,
- Masataka Fumoto,
- Morio Nagira,
- Fumihisa Nakata,
- Takao Hashiguchi,
- Tadaki Suzuki,
- Shinya Omoto,
- Hideki Hasegawa
Affiliations
- Tomoyuki Homma
- Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd.
- Noriyo Nagata
- Department of Pathology, National Institute of Infectious Diseases
- Masayuki Hashimoto
- Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd.
- Naoko Iwata-Yoshikawa
- Department of Pathology, National Institute of Infectious Diseases
- Naomi M. Seki
- Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd.
- Nozomi Shiwa-Sudo
- Department of Pathology, National Institute of Infectious Diseases
- Akira Ainai
- Department of Pathology, National Institute of Infectious Diseases
- Keiji Dohi
- Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd.
- Eiji Nikaido
- Laboratory for Bio-Modality Research, Shionogi & Co., Ltd.
- Akiko Mukai
- UMN Pharma Inc.
- Yuuta Ukai
- Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd.
- Takayuki Nakagawa
- Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd.
- Yusuke Shimo
- Laboratory for Drug Discovery and Disease Research, Shionogi & Co., Ltd.
- Hiroki Maeda
- Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd.
- Seiki Shirai
- Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd.
- Miwa Aoki
- Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd.
- Takuhiro Sonoyama
- Medical Science Department, Shionogi & Co., Ltd.
- Mamoru Sato
- UMN Pharma Inc.
- Masataka Fumoto
- Laboratory for Bio-Modality Research, Shionogi & Co., Ltd.
- Morio Nagira
- Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd.
- Fumihisa Nakata
- UMN Pharma Inc.
- Takao Hashiguchi
- Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University
- Tadaki Suzuki
- Department of Pathology, National Institute of Infectious Diseases
- Shinya Omoto
- Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd.
- Hideki Hasegawa
- Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases
- DOI
- https://doi.org/10.1038/s41598-024-52772-3
- Journal volume & issue
-
Vol. 14,
no. 1
pp. 1 – 3
Abstract
No abstracts available.